Advertisement

Novel Interventional Techniques for Acute Coronary Syndromes

  • David R. HolmesJr.
  • Robert S. Schwartz
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 217)

Abstract

The introduction of percutaneous transluminal coronary angioplasty (PTCA) in 1977 has revolutionized modern cardiology.1 It not only has offered an alternative means for treating patients with acute coronary syndromes but also stimulated interest in the pathophysiology of these syndromes. Percutaneous revascularization procedures have become the treatment of choice for patients with single vessel disease requiring revascularization and similarly provide an excellent option for selected patients with multivessel coronary artery disease.2-6 The annual number of dilatation procedures now exceeds the number of coronary bypass surgical procedures.

Keywords

Unstable Angina Chronic Total Occlusion Rotational Atherectomy Initial Success Rate Intracoronary Thrombus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Gruentzig AR, Senning A, Sieganthaler WE. Nonoperative dilatation of coronary artery stenosis: Percutaneous transluminal coronary angioplasty. N Engl J Med 1979: 301: 61.CrossRefGoogle Scholar
  2. 2.
    Holmes DR, Vlietstra RE. Balloon angioplasty in acute and chronic coronary artery disease. JAMA 1989: 261: 2109.PubMedCrossRefGoogle Scholar
  3. 3.
    Detre K, et al. Percutaneous transluminal coronary’angioplasty in 1985–1986 and 1977-1981–. N Engl J Med 1988: 318: 267.CrossRefGoogle Scholar
  4. 4.
    Landau C, Lange RA, Hillis LD. Medical Progress: Percutaneous transluminal coronary angioplasty. N Engl J Med 1994: 330: 981.PubMedCrossRefGoogle Scholar
  5. 5.
    Detre K, et al. One year follow-up results of the 1985-86 National Heart, Lung, and Blood Institute’s Percutaneous Transluminal Coronary Angioplasty Registry. Circulation 1989: 80: 421.PubMedCrossRefGoogle Scholar
  6. 6.
    Berger PB, et al. Initial results and long-term outcome of coronary angioplasty in chronic mild angina pectoris. Am J Cardiol 1993: 71: 1396.PubMedCrossRefGoogle Scholar
  7. 7.
    Fuster V, et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (Part 1). N Engl J Med 1992: 326: 242.PubMedCrossRefGoogle Scholar
  8. 8.
    Fuster V, et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (Part 2). N Engl J Med 1992: 326: 310.PubMedCrossRefGoogle Scholar
  9. 9.
    Mabin TA, et al. Intracoronary thrombus: Role in coronary occlusion complicating percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1985: 5: 198.PubMedCrossRefGoogle Scholar
  10. 10.
    Sugrue D, et al. Coronary thrombus as a risk factor for acute vessel occlusion during percutaneous transluminal coronary angioplasty: Improving results. Br Heart J 1986: 56: 62.PubMedCrossRefGoogle Scholar
  11. 11.
    Vaitkus P, Herrmann H, Laskey W. Management and immediate outcome of patients with intracoronary thrombus during PTCA. Am Heart J 1992: 124: 1.PubMedCrossRefGoogle Scholar
  12. 12.
    Reeder GS, et al. Intracoronary thrombus: Still a risk factor for PTCA failure. Cathet Cardiovasc Diagn in press.Google Scholar
  13. 13.
    Topol EJ, et al. CAVEAT Study Group: A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. N Engl J Med 1993: 329: 221.PubMedCrossRefGoogle Scholar
  14. 14.
    Holmes DR Jr, et al. A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions. Circulation in press.Google Scholar
  15. 15.
    Bairn DS, et al. Evaluating new devices: Acute (in hospital) results from the New Approaches to Coronary Intervention Registry. Circulation 1994: 89: 471.CrossRefGoogle Scholar
  16. 16.
    Safian RD, et al. Clinical and angiographic results of transluminal extraction coronary at herectomy in saphenous vein bypass grafts. Circulation 1994: 89: 302.PubMedCrossRefGoogle Scholar
  17. 17.
    Vandormael M, et al. Comparison of excimer lasers, rotational atherectomy and balloon angioplasty for complex disease: The ERBAC study. J Am Coll Cardiol 1994: 23. (Special Iss): 484AGoogle Scholar
  18. 18.
    Holmes DR Jr, Klein LW, Litvack F. Lesion morphology and acute outcome after excimer laser angioplasty: A prospective evaluation. Circulation: in press.Google Scholar
  19. 19.
    Topaz O, et al. Laser facilitated angioplasty and thrombolysis for acute myocardial infarction complicated by prolonged or recurrent chest pain. Cathet Cardiovasc Diagn 1993: 28: 7.PubMedCrossRefGoogle Scholar
  20. 20.
    Knopf WD, et al. Multicenter registry report: Holmium laser angioplasty in coronary arteries. Circulation 1992: 86(Suppl I): I–511.Google Scholar
  21. 21.
    Estella P, et al. Intracoronary thrombus increases the risk of excimer laser coronary angioplasty. Circulation 1992: 86(Suppl I): I–654.Google Scholar
  22. 22.
    Gregory KW: Laser thrombolysis. In, Textbook of Interventional Cardiology. Topol EJ (ed), Saunders, 1994: 982.Google Scholar
  23. 23.
    Gregory KW, et al. Coronary artery laser thrombolysis in acute canine myocardial infarction. Circulation 1989: 80: 523.Google Scholar
  24. 24.
    Gregory KW, et al. Laser thrombolysis in acute myocardial infarction. J Am Coll Cardiol 1993: 21(Suppl A): 2898A.Google Scholar
  25. 25.
    Roubin GS, et al. Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty. Circulation 1992: 85: 916.PubMedCrossRefGoogle Scholar
  26. 26.
    George BS, et al. Multicenter investigation of coronary stenting to treat acute or threatened closure after PTCA: Clinical and angiographic outcomes. J Am Coll Cardiol 1993: 22: 135.PubMedCrossRefGoogle Scholar
  27. 27.
    Schatz RA, et al. Clinical experience with the Palmaz-Schatz coronary stent. J Am Coll Cardiol 1991: 17(Suppl B): 155B.PubMedCrossRefGoogle Scholar
  28. 28.
    Colombo A, et al. Coronary stenting: Single institutional experience with the initial 100 cases using the Palmaz-Schatz stent. Cathet Cardiovasc Diagn 1992: 26: 171.PubMedCrossRefGoogle Scholar
  29. 29.
    Hearn JA, et al. Clinical and angiographic outcomes after coronary stenting for acute or threatened closure after PTCA: Initial results with a balloon expandable stainless steel design. Circulation 1993: 88: 2086.PubMedCrossRefGoogle Scholar
  30. 30.
    Liu MW, et al. Risk stratification of stent thrombosis following intracoronary stenting for acute or threatened closure. A Cook stent multicenter registry study. Circulation 1993: 88(Suppl A): I–122.Google Scholar
  31. 31.
    Barragan P, Sainsous J, Silvestri M. Ticlopidine and subcutaneous heparin as an alternative regimen following coronary stenting. Cathet Cardiovasc Diagn 1994: 32: 133.PubMedCrossRefGoogle Scholar
  32. 32.
    Reeder GS, Lapeyre AC, Edwards WD, Holmes DR. Aspiration thrombectomy for removal of coronary thrombus. Am J Cardiol 1992: 70: 107.PubMedCrossRefGoogle Scholar
  33. 33.
    Fram DB, et al. Localized intramural drug delivery during balloon angioplasty using hydrogel-coated balloons and pressure-augmented diffusion. J Am Coll Cardiol 1994: 23: 1570.PubMedCrossRefGoogle Scholar
  34. 34.
    Nunes GL, et al. Local delivery of a synthetic antithrombin with a hydrogel-coated angioplasty balloon catheter inhibits platelet-dependent thrombosis. J Am Coll Cardiol 1994: 23: 1578.PubMedCrossRefGoogle Scholar
  35. 35.
    Mitchel JF, et al. Inhibition of platelet deposition and lysis of intracoronary thrombus during balloon angioplasty using urokinase-coated hydrogel balloons. J Am Cardiol in press.Google Scholar
  36. 36.
    Drasler WJ, et al. Rheolytic catheter for percutaneous removal of thrombus. Radiology 1992: 182: 263.PubMedGoogle Scholar
  37. 37.
    Rosenschein U, et al. Ultrasonic angioplasty in totally occluded peripheral arteries. Circulation 1991: 83: 1976.PubMedCrossRefGoogle Scholar
  38. 38.
    Steffen W, Siegel RJ. Ultrasound angioplasty: A review. J Interventional Cardiol 1993: 6: 77.CrossRefGoogle Scholar
  39. 39.
    Siegel RJ, et al. Clinical trial of percutaneous peripheral ultrasound angioplasty. J Am Coll Cardiol 1993: 22: 480.PubMedCrossRefGoogle Scholar
  40. 40.
    Siegel RJ, et al. Use of therapeutic ultrasound in PTCA. Experimental in vitro studies and initial clinical experience. Circulation 1994: 89: 1587.PubMedCrossRefGoogle Scholar
  41. 41.
    Soria I, Hassinger NL, Owen WJ. Local delivery of hirudin into rabbit carotid arteries with an ionotophoretic catheter. Circulation 1993: 88: 3552A.Google Scholar
  42. 42.
    Fernandez-Ortiz A, et al. A new approach for local intravascular drug delivery: ionotophoretic balloon. Circulation 1994: 89: 1518.PubMedCrossRefGoogle Scholar
  43. 43.
    Ambrose JA, et al. Adjunctive thrombolytic therapy during angioplasty for ischemic rest angina. Results of the TAUSA trial. Circulation 1994: 90: 69.PubMedCrossRefGoogle Scholar
  44. 44.
    EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein receptor in high risk coronary angioplasty. N Engl J Med 1994: 330: 956.CrossRefGoogle Scholar
  45. 45.
    Topol EJ, et al. Randomized trial of coronary intervention with antibody against platelet IIb/ IIIa integrin for reduction of clinical restenosis. Results at six months. Lancet 1994: 343: 881.PubMedCrossRefGoogle Scholar
  46. 46.
    Topol EJ, et al. Use of a direct antithrombin, Hirulog, in place of heparin during coronary angioplasty. Circulation 1993: 87: 1622.PubMedCrossRefGoogle Scholar
  47. 47.
    Lefkovitz J, Topol EJ. Direct thrombin inhibitors in cardiovascular medicine. Circulation in press.Google Scholar
  48. 48.
    Cannon CP, et al. A pilot trial of recombinant desulfatohirudin compared to heparin in conjunction with tissue plasminogen activator and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial. J Am Coll Cardiol 1994: 23: 993.PubMedCrossRefGoogle Scholar
  49. 49.
    Topol EJ, et al. Recombinant hirudin for unstable angina pectoris. A multicenter randomized angiographic trial. Circulation 1994: 89: 1557.PubMedCrossRefGoogle Scholar
  50. 50.
    Antman EM for the TIMI 9A Investigators. Hirudin in acute myocardial infarction: A safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI 9) trial. Circulation in press.Google Scholar
  51. 51.
    Topol EJ for the GUSTO Investigators. A randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. Circulation in press.Google Scholar

Copyright information

© Springer Science+Business Media New York 1999

Authors and Affiliations

  • David R. HolmesJr.
  • Robert S. Schwartz

There are no affiliations available

Personalised recommendations